Trials / Conditions / Renal Failure Chronic Requiring Hemodialysis

Renal Failure Chronic Requiring Hemodialysis

28 registered clinical trials studyying Renal Failure Chronic Requiring Hemodialysis.

Status	Trial	Sponsor	Phase
Unknown	Serum Ceftazidime Concentrations in Hemodialysis Patients NCT03634904	Centre Hospitalier Universitaire de Charleroi	N/A
Completed	BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients NCT02825589	Mahidol University	N/A
Completed	VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC NCT02685995	University of Pennsylvania	N/A
Unknown	Sleep Disturbance in Patients With End-Stage Renal Disease NCT02583347	Beaumont Hospital	—
Completed	Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis NCT02259413	University of Manitoba	N/A
Unknown	Pharmaceutical Care in Ambulatory Hemodialysis Patients NCT02452788	Hospital Moinhos de Vento	N/A
Unknown	Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis NCT02264964	Shanghai Changzheng Hospital	N/A
Completed	Transplant Navigator Dissemination NCT01981603	Catherine Sullivan	N/A
Terminated	Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients. NCT01982864	University Hospital, Limoges	Phase 4
Completed	Mechanisms of Intradialytic Hypertension NCT01947673	Emory University	N/A
Withdrawn	Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Q NCT01946841	Lactalis	Phase 2
Completed	Performance Comparison of Revaclear With Larger Dialyzer NCT01722695	Vantive Health LLC	N/A
Completed	Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the NCT01578421	Kantonsspital Aarau	N/A
Completed	Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients NCT01448174	Poznan University of Medical Sciences	Phase 4
Completed	Blood Pressure in Dialysis Patients NCT01421771	University of New Mexico	N/A
Completed	Temocillin Pharmacokinetic in Hemodialysis NCT02285075	AZ Sint-Jan AV	Phase 4
Unknown	Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients NCT01356563	Sin-Lau Hospital	N/A
Completed	Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2) NCT01322347	Rockwell Medical Technologies, Inc.	Phase 3
Completed	A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis NCT01181544	Vantive Health LLC	N/A
Completed	Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients NCT01320202	Rockwell Medical Technologies, Inc.	Phase 3
Terminated	Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D NCT01312441	Albany College of Pharmacy and Health Sciences	Phase 4
Completed	Hemodialysis Vitamin D Pilot NCT01214928	St. Joseph's Healthcare Hamilton	N/A
Completed	Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease NCT00967993	Keryx Biopharmaceuticals	—
Withdrawn	Effects of Intensified Sodium Management in Hemodialysis Patients NCT01015313	Renal Research Institute	N/A
Completed	Study to Evaluate Daptomycin Given During Dialysis and After Dialysis NCT00882557	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 1
Completed	Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C NCT01272479	Istanbul University	—
Unknown	Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Adminis NCT00560976	Soroka University Medical Center	N/A
Completed	Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study NCT00890045	Merit Medical Systems, Inc.	N/A